We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Gallus Enters Clinical cGMP Manufacturing Agreement with Symphogen

News   Mar 01, 2014

 
Gallus Enters Clinical cGMP Manufacturing Agreement with Symphogen
 
 
Advertisement
 

RELATED ARTICLES

Neuropilin-1 Identified as a Facilitator for SARS-CoV-2 Entry Into Cells’ Interior

News

The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2. An international research team under German-Finnish coordination has now identified neuropilin-1 as a factor that can facilitate SARS-CoV-2 entry into the cells’ interior.

READ MORE

UK Researchers Set To Explore Human Challenge Studies for COVID-19 Vaccine Development

News

Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.

READ MORE

Can Edible Insects Trigger Food Allergies?

News

It's estimated that more than 1900 insect species are consumed worldwide and probable they will be used in food increasingly in the future. Although only a few cases of allergies caused by insect components have been described to date, there is considerable potential for cross-reaction. So, a joint project is looking to develop allergen detection methods for insect components.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE